SUCAMPO PHARMACEUTICALS, INC. Research and Development in Process
SUCAMPO PHARMACEUTICALS, INC. reported Research and Development in Process of $186.60 million for the 9-month period ending 2017-09-30, per its 10-Q filed 2017-11-01.
Discontinued › Notes
us-gaap:ResearchAndDevelopmentInProcess · last filed 2017-11-01
- SUCAMPO PHARMACEUTICALS, INC. research and development in process for the quarter ending 2017-09-30 was $0.00.
- SUCAMPO PHARMACEUTICALS, INC. research and development in process for the quarter ending 2017-06-30 was $186.60M.
| Period end | Research and Development in Process 3 month | Research and Development in Process 6 month | Research and Development in Process 9 month |
|---|---|---|---|
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-01 | $186.60M derived: sum of 2 quarters · filed 2017-11-01 | $186.60M 10-Q · filed 2017-11-01 |
| 2017-06-30 | $186.60M 10-Q · filed 2017-08-02 | $186.60M 10-Q · filed 2017-08-02 |